13F

Stock

Regeneron Pharmaceuticals, Inc.

REGN · held by 16 managers

Reported value

$1.05B

Holders

16

+0 new · −0 exited

Holders’ est. mark

−$36.2M

Price effect on 10 books still in the name

Largest holder

$715.7M

NORGES BANK

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
NORGES BANK1.13M$715.7MHeld
BARCLAYS PLC321.4K$203.8M−$25.1MCut−$70.6M
Marex Group plc70.9K$44.9M−$5.49MCut−$5.11M
DANSKE BANK A/S63.3K$40.2M−$4.69MCut−$2.65M
Sanctuary Advisors, LLC34.1K$21.6MHeld
OP Asset Management Ltd11.7K$7.42MHeld
Swiss Life Asset Management Ltd10.4K$6.6M−$708.1KAdded$69.5K
Pine Valley Investments Ltd Liability Co6.36K$4.04MHeld
Leonteq Securities AG3.81K$2.37M−$165.2KAdded$1.07M
INDEPENDENT FINANCIAL GROUP, LLC1.03K$652.6KHeld
Savant Capital, LLC890$564.5KHeld
Ramiah Investment Group663$420.5K−$37.8KAdded$75.7K
Aventura Private Wealth, LLC620$393.2K−$47.6KCut−$41.3K
Prestige Wealth Management Group LLC90$57.1K−$7.03KCut−$14.9K
Clark Wealth Partners5$3.17K−$391Cut−$391
CHESAPEAKE ASSET MANAGEMENT LLC1$634−$78Cut−$78

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.